G2B BioSolutions ApS Financials, key figures and credit report
Gross profit 44.8 kDKK FY 2025 -89.7% vs 2024
EBIT 8.5 kDKK FY 2025 -97.8% vs 2024
Net debt 628.5 kDKK FY 2025 -0.8% vs 2024
Quick ratio 0.3 FY 2025 +0 vs 2024
Income statement (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Fiscal period length | 12 | 12 | 12 | 12 | 12 |
| Net sales | |||||
| Gross profit | -28.55 | - 171.18 | - 740.77 | 435.67 | 44.82 |
| Employee benefit expenses | -41.37 | - 760.64 | -54.41 | ||
| Total depreciation | -36.29 | ||||
| EBIT | -28.55 | - 212.56 | -1 501.41 | 381.26 | 8.53 |
| Other financial expenses | -0.09 | -4.79 | -12.37 | -10.52 | -39.00 |
| Pre-tax profit | -28.64 | - 217.35 | -1 513.78 | 370.74 | -30.48 |
| Income taxes | -1.20 | 167.34 | |||
| Net earnings | -28.64 | - 218.55 | -1 513.78 | 370.74 | 136.86 |
Assets (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Intangible rights | 262.75 | 343.24 | |||
| Intangible assets total | 262.75 | 343.24 | |||
| Tangible assets total | |||||
| Holdings in group member companies | 40.00 | ||||
| Investments total | 40.00 | ||||
| Non-curr. owed by group member comp. | 40.00 | ||||
| Long term receivables total | 40.00 | ||||
| Inventories total | |||||
| Prepayments and accrued income | 46.00 | 3.13 | |||
| Current other receivables | 7.01 | 2.99 | 47.07 | 31.73 | 203.46 |
| Short term receivables total | 7.01 | 48.99 | 50.19 | 31.73 | 203.46 |
| Cash and bank deposits | 7.29 | 18.51 | 257.43 | 88.07 | |
| Cash and cash equivalents | 7.29 | 18.51 | 257.43 | 88.07 | |
| Balance sheet total (assets) | 14.30 | 67.50 | 90.19 | 591.90 | 634.77 |
Equity and liabilities (kDKK)
2021 | 2022 | 2023 | 2024 | 2025 | |
|---|---|---|---|---|---|
| Share capital | 40.00 | 40.00 | 40.00 | 40.00 | 40.00 |
| Retained earnings | -28.64 | - 247.19 | -1 760.98 | -1 390.24 | |
| Profit of the financial year | -28.64 | - 218.55 | -1 513.78 | 370.74 | 136.86 |
| Shareholders equity total | 11.36 | - 207.19 | -1 720.98 | -1 350.24 | -1 213.37 |
| Non-current loans from credit institutions | 500.00 | 500.00 | 530.00 | ||
| Non-current owed to group member | 305.62 | 186.62 | |||
| Non-current liabilities total | 500.00 | 805.62 | 716.62 | ||
| Current loans from credit institutions | 185.51 | ||||
| Current trade creditors | 0.10 | 15.00 | 68.83 | 15.00 | 55.13 |
| Current owed to group member | 85.12 | ||||
| Other non-interest bearing current liabilities | 2.84 | 259.69 | 1 056.82 | 1 036.40 | 1 076.40 |
| Current liabilities total | 2.94 | 274.70 | 1 311.17 | 1 136.52 | 1 131.52 |
| Balance sheet total (liabilities) | 14.30 | 67.50 | 90.19 | 591.90 | 634.77 |
Secure checkout
Buy AI Credit Risk Report
Pay by card and the report is generated automatically and sent to your email. One-time payment – no subscription.
How it works
- 01 You pay €3 (incl. VAT) securely by card via Stripe.
- 02 You enter your email address in Stripe's payment window – the report is sent there.
- 03 The report is generated automatically and sent as a PDF within 30 minutes.
- 04 If generation should fail, you are not charged.
- 05 You receive the receipt by email once the report has been generated and completed.
Do you want to buy the AI Credit Risk Report (3 EUR / report)?
The report is sent to the email address you enter in Stripe's payment window. Please also check your spam folder. Questions? Write to info@creditreports.dk.
Page generated